Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-09-15

FDA Approved: NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

FDA approved a supplemental application for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (Sandoz) to support a generic version of this antibiotic/steroid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)

Snippet

SUPPL AP for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)